Tirzepatide 10MG
$74.99In Stock
Tirzepatide is a dual GIP and GLP-1 receptor agonist — among the most actively studied next-generation incretin compounds in metabolic research.
In stock
Wed, Jul 1 – Sun, Jul 5
≥ 99% purity
scannable per batch
Volume Pricing
Research Overview
Tirzepatide is a synthetic peptide engineered to act as a dual agonist at both the GIP and GLP-1 receptors. It is a benchmark compound in modern metabolic and glucose-regulation research.
Preclinical and clinical research has examined tirzepatide across glycemic-control, body-composition, and satiety endpoints, making it one of the most referenced dual-incretin compounds in metabolic-research models.
Research Focus
Mechanism (Research Context)
Tirzepatide is studied for its simultaneous activation of the GIP and GLP-1 receptors, a combination observed to influence insulin secretion, satiety signaling, and energy balance in research models.
Intended Use
This compound is strictly intended for in vitro laboratory research. It is not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics.
Legal Disclaimer
This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Usage is restricted to certified laboratories and qualified research professionals.
Terms of Sale
All sales by Codex Research are final. Buyers must be qualified professionals and assume full responsibility for safe handling and regulatory compliance. Every batch is independently verified by accredited third-party laboratories. Batch-specific Certificates of Analysis are available on our COAs page.
For Research Use Only · Not for Human Consumption
Be the first to review “Tirzepatide 10MG”
Related products
Research Peptides
MOTS-c is a mitochondrial-derived peptide that activates AMPK signaling, examined for metabolic regulation, insulin sensitivity, and exercise-mimetic effects.
Research Peptides
MT-2 is a synthetic analog of α-MSH that activates melanocortin receptors, researched for melanogenesis, pigmentation, and related signaling pathways.
Research Peptides
GHK-Cu is a naturally occurring copper-binding tripeptide — one of the most studied peptides in collagen, skin-remodeling, and wound-repair research.
Research Peptides
TB-500 is a synthetic fragment of Thymosin β-4 that regulates actin and promotes angiogenesis, examined for muscle, tendon, and connective-tissue recovery.
Research Peptides
Semaglutide is a long-acting GLP-1 receptor agonist that modulates incretin signaling, appetite regulation, and glucose homeostasis in metabolic research models.
Research Peptides
Retatrutide is a first-in-class triple receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously — among the most actively studied next-generation incretin compounds in metabolic research.
Research Peptides
Tesamorelin is a stabilized GHRH analog that stimulates endogenous growth-hormone release, examined for visceral fat reduction and body-composition research.
Research Peptides
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in gastric juice — among the most extensively studied peptides in tissue-repair and cytoprotection research.
Reviews
There are no reviews yet.